Sucrosomial® Iron: A New Generation Iron for Improving Oral Supplementation
Open accessThe DOI matches its Crossref record; 81 of the 82 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Iron deficiency (ID) is usually treated with oral iron salts, but up to 50% of patients complain of gastrointestinal side effects, leading to reduced compliance with treatment. Intravenous (IV) iron formulations are increasingly safe, but there is still a risk of infusion, hypersensitivity reactions and the need for venous access and infusion monitoring. Sucrosomial® Iron (SI) is an innovative oral iron formulation in which ferric pyrophosphate is protected by a phospholipid bilayer plus a sucrester matrix (sucrosome), which is absorbed through para-cellular and trans-cellular routes (M cells). This confers SI’s unique structural, physicochemical and pharmacokinetic characteristics, together with its high iron bioavailability and excellent gastrointestinal tolerance. The analysis of the available evidence supports oral SI iron as a valid option for ID treatment, which is more efficacious and tolerable than oral iron salts. SI has also demonstrated a similar effectiveness, with lower risks, in patients usually receiving IV iron (e.g., chronic kidney disease, cancer, bariatric surgery). Thus, oral SI emerges as a valuable first option for treating ID, especially for subjects with intolerance to iron salts or those for whom iron salts are inefficacious. Moreover, SI should also be considered as an alternative to IV iron for initial and/or maintenance treatment in different patient populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Prevalence of iron deficiency across pathologies. (Data taken from references [5,6,7,8,9,10,11,12,13]).](https://figures.cochat.ai/paper-figures/9feb25a1d42c49aca53a32d1f6c2c214/sucrosomial-iron-a-new-generation-iron-for-improving-oral-supplementation-figure-1.jpg)


![Figure 4 Gastro-resistance and intestinal absorption of Sucrosomial® iron. (A) Gastro-resistant properties of Sucrosomial® iron compared to a sucrester-free iron preparation in an in-vitro simulated gastric fluid digestion at pH 1.2. (B) The involvement of M cells in Sucrosomial® iron uptake was evaluated using an in vitro CACO2/RajiB co-culture. The iron to protein ratio was significantly increased in co-culture cells treated with Sucrosomial® iron (SI), compared to other oral iron formulations: ferrous sulfate (FS), ferrous ascorbate (FeASC), ferrous ethylene-diamine-tetra-acetate (FeEDTA), ferrous bisglycinate (FeBIS), and control (no iron) (data are mean ± SEM, * p < 0.05) (Adapted from references [41,42]).](https://figures.cochat.ai/paper-figures/83fa6be5e09541909c5e01b4a5810dae/sucrosomial-iron-a-new-generation-iron-for-improving-oral-supplementation-figure-4.jpg)
![Figure 5 Bioavailability experiments on CACO-2 cells. Ferritin expression by cells treated with Sucrosomial® iron (SI) was significantly increased, compared to cells treated with ferrous sulfate (FS), phospholipid containing ferric pyrophosphate (Lipofer®), or micronized, dispersible ferric pyrophosphate (SunActive®) (A) or different iron salts, FS, ferric pyrophosphate (FePYR), ferrous ascorbate (FeASC), ferrous ethylene-diamine-tetra-acetate (FeEDTA), ferrous bisglycinate (FeBIS), and control (no iron) (B) (Data are mean ± SEM, * p < 0.001 SI vs. other iron compounds) (Adapted from references [41,45]).](https://figures.cochat.ai/paper-figures/90057c5c3069409ba253d8732f1c9c9f/sucrosomial-iron-a-new-generation-iron-for-improving-oral-supplementation-figure-5.jpg)
![Figure 6 Iron supplementation in anemic piglets and mice. (A) Hemoglobin concentration in anemic piglets treated with iron dextran (FeDEX) or Sucrosomial® iron (SI) (Data are mean ± SD; * p < 0.001, treatment vs. anemic; ** p < 0.001, SI vs. FeDEX). (B) Change in hemoglobin levels in anemic mice after a 14-day treatment with Sucrosomial® iron (SI) or ferrous sulfate (FS). (Data are mean ± SD; * p < 0.01, SI or FS vs. saline; ** p < 0.05, FS vs. vehicle) (Adapted from references [46,47]).](https://figures.cochat.ai/paper-figures/5c74524764144e00aff389f257b54e0b/sucrosomial-iron-a-new-generation-iron-for-improving-oral-supplementation-figure-6.jpg)
![Figure 7 Comparative efficacy of different oral iron formulations for treating bleeding-induced moderate-to-severe anemia. SunActive®, micronized ferric pyrophosphate. Each oral iron formulation was tested in 60 patients (Data taken from reference [89]).](https://figures.cochat.ai/paper-figures/9eb6a9b1ed3d4d498f2347d5433eb672/sucrosomial-iron-a-new-generation-iron-for-improving-oral-supplementation-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Pre-clinical data indicate that it may be more tolerable than other oral iron formulations whilst having similar effectiveness at restoring iron levels [32].”
From Oral Iron Supplementation—Gastrointestinal Side Effects and the Impact on the Gut Microbiota (2021) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
A systematic analysis of global anemia burden from 1990 to 2010
Kassebaum, N. J., Jasrasaria, R., Naghavi, M., Wulf, S. K., Johns, N., Lozano, R., Regan, M., Weatherall, D., Chou, D. P., Eisele, T. P., et al. (2014) · Blood · doi:10.1182/blood-2013-06-508325 · Cited by 2,075
ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease
Rubio-Tapia, A., Hill, I. D., Kelly, C. P., Calderwood, A. H., & Murray, J. A. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.79 · Cited by 1,681
Camaschella, C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1401038 · Cited by 1,678 · cited 3×
“In turn, hepcidin binds ferroportin, especially at the enterocytes, promoting its internalization and degradation, thus preventing iron absorption, while iron recirculation from macrophages seems to be less affected [4,14,55].”
BackgroundHepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
Ganz, T. (2003) · Blood · doi:10.1182/blood-2003-03-0672 · Cited by 1,544 · cited 2×
“In turn, hepcidin binds ferroportin, especially at the enterocytes, promoting its internalization and degradation, thus preventing iron absorption, while iron recirculation from macrophages seems to be less affected [4,14,55].”
BackgroundClinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage
Carson, J. L., Guyatt, G., Heddle, N. M., Grossman, B. J., Cohn, C. S., Fung, M. K., Gernsheimer, T., Holcomb, J. B., Kaplan, L. J., Katz, L. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.9185 · Cited by 1,113
International consensus statement on the peri‐operative management of anaemia and iron deficiency
Muñoz, M., Acheson, A. G., Auerbach, M., Besser, M., Habler, O., Kehlet, H., Liumbruno, G. M., Lasocki, S., Meybohm, P., Rao Baikady, R., et al. (2017) · Anaesthesia · doi:10.1111/anae.13773 · Cited by 876
Tolkien, Z., Stecher, L., Mander, A. P., Pereira, D. I. A., & Powell, J. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0117383 · Cited by 833 · cited 2×
“In addition, up to 50% of patients on oral iron (depending on the iron formulation) report gastrointestinal side effects due to the direct toxicity of ionic iron, which may lead to reduced tolerance and adherence to iron supplementation [25,26].”
BackgroundMicrofold (M) cells: important immunosurveillance posts in the intestinal epithelium
Mabbott, N. A., Donaldson, D. S., Ohno, H., Williams, I. R., & Mahajan, A. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.30 · Cited by 721 · cited 2×
“M cells have been shown to provide a pathway for delivering orally administered vesicle-like particles to the lymphatic system [43,44].”
BackgroundDignass, A. U., Gasche, C., Bettenworth, D., Birgegård, G., Danese, S., Gisbert, J. P., Gomollon, F., Iqbal, T., Katsanos, K., Koutroubakis, I., et al. (2015) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jju009 · Cited by 622
Serum ferritin concentration and iron stores in normal subjects
Walters, G. O., Miller, F. M., & Worwood, M. (1973) · Journal of Clinical Pathology · doi:10.1136/jcp.26.10.770 · Cited by 615
Moretti, D., Goede, J. S., Zeder, C., Jiskra, M., Chatzinakou, V., Tjalsma, H., Melse-Boonstra, A., Brittenham, G., Swinkels, D. W., & Zimmermann, M. B. (2015) · Blood · doi:10.1182/blood-2015-05-642223 · Cited by 547
Cappellini, M. D., Comin‐Colet, J., de Francisco, A., Dignass, A., Doehner, W., Lam, C. S., Macdougall, I. C., Rogler, G., Camaschella, C., Kadir, R., et al. (2017) · American Journal of Hematology · doi:10.1002/ajh.24820 · Cited by 502
Macdougall, I. C., Bircher, A. J., Eckardt, K.-U., Obrador, G. T., Pollock, C. A., Stenvinkel, P., Swinkels, D. W., Wanner, C., Weiss, G., Chertow, G. M., et al. (2016) · Kidney International · doi:10.1016/j.kint.2015.10.002 · Cited by 482
Lewis, G. D., Malhotra, R., Hernandez, A. F., McNulty, S. E., Smith, A., Felker, G. M., Tang, W. H. W., LaRue, S. J., Redfield, M. M., Semigran, M. J., et al. (2017) · JAMA · doi:10.1001/jama.2017.5427 · Cited by 480
Diagnosis and Management of Iron-Deficiency Anaemia
COOK, J. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.08.022 · Cited by 452 · cited 1×
“As a result, ID without anemia is almost invariably a casual laboratory finding [20].”
BackgroundDaru, J., Zamora, J., Fernández-Félix, B. M., Vogel, J., Oladapo, O. T., Morisaki, N., Tunçalp, Ö., Torloni, M. R., Mittal, S., Jayaratne, K., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30078-0 · Cited by 436 · cited 1×
“was also associated with an increased risk of peri-partum mortality [58].”
BackgroundStoffel, N. U., Cercamondi, C. I., Brittenham, G., Zeder, C., Geurts-Moespot, A. J., Swinkels, D. W., Moretti, D., & Zimmermann, M. B. (2017) · The Lancet Haematology · doi:10.1016/s2352-3026(17)30182-5 · Cited by 435 · cited 1×
“Single low doses of iron supplements (40–60 mg/day) are associated with less gastrointestinal side effects and lower hepcidin secretion, resulting in better treatment compliance and enhanced fractional absorption [27,28].”
BackgroundMacdougall, I. C., Bock, A. H., Carrera, F., Eckardt, K.-U., Gaillard, C., Van Wyck, D., Roubert, B., Nolen, J. G., Roger, S. D., & on behalf of the FIND-CKD Study Investigators (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu201 · Cited by 328
Lee, T., Clavel, T., Smirnov, K., Schmidt, A., Lagkouvardos, I., Walker, A., Lucio, M., Michalke, B., Schmitt-Kopplin, P., Fedorak, R., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-309940 · Cited by 324
Shepshelovich, D., Rozen-Zvi, B., Avni, T., Gafter, U., & Gafter-Gvili, A. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.04.018 · Cited by 322
Tolerability of different oral iron supplements: a systematic review
Cancelo-Hidalgo, M. J., Castelo-Branco, C., Palacios, S., Haya-Palazuelos, J., Ciria-Recasens, M., Manasanch, J., & Pérez-Edo, L. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.761599 · Cited by 320 · cited 2×
“In addition, up to 50% of patients on oral iron (depending on the iron formulation) report gastrointestinal side effects due to the direct toxicity of ionic iron, which may lead to reduced tolerance and adherence to iron supplementation [25,26].”
BackgroundHow we diagnose and treat iron deficiency anemia
Auerbach, M., & Adamson, J. W. (2016) · American Journal of Hematology · doi:10.1002/ajh.24201 · Cited by 308
Disorders of iron metabolism. Part II: iron deficiency and iron overload
Muñoz, M., García-Erce, J. A., & Remacha, Á. F. (2011) · Journal of Clinical Pathology · doi:10.1136/jcp.2010.086991 · Cited by 292
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines
Aapro, M., Beguin, Y., Bokemeyer, C., Dicato, M., Gascón, P., Glaspy, J., Hofmann, A., Link, H., Littlewood, T., Ludwig, H., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdx758 · Cited by 288
Time-Dependent Associations between Iron and Mortality in Hemodialysis Patients
Kalantar-Zadeh, K., Regidor, D. L., McAllister, C. J., Michael, B., & Warnock, D. G. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005040423 · Cited by 285
Muñoz, M., Laso‐Morales, M. J., Gómez‐Ramírez, S., Cadellas, M., Núñez‐Matas, M. J., & García‐Erce, J. A. (2017) · Anaesthesia · doi:10.1111/anae.13840 · Cited by 229
Self-citationPre-operative anaemia: prevalence, consequences and approaches to management.
Múñoz, M., Gómez‐Ramírez, S., Campos, A., Ruiz, J. C., & Liumbruno, G. M. (2015) · PubMed · doi:10.2450/2015.0014-15 · Cited by 222
Self-citationAre we giving too much iron? Low-dose iron therapy is effective in octogenarians
Rimon, E., Kagansky, N., Kagansky, M., Mechnick, L., Mashiah, T., Namir, M., & Levy, S. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.01.065 · Cited by 221
A randomized trial of intravenous and oral iron in chronic kidney disease
Agarwal, R., Kusek, J. W., & Pappas, M. K. (2015) · Kidney International · doi:10.1038/ki.2015.163 · Cited by 200
Modern iron replacement therapy: clinical and pathophysiological insights
Girelli, D., Ugolini, S., Busti, F., Marchi, G., & Castagna, A. (2018) · International Journal of Hematology · doi:10.1007/s12185-017-2373-3 · Cited by 188
Muñoz, M., Peña‐Rosas, J. P., Robinson, S., Milman, N., Holzgreve, W., Breymann, C., Goffinet, F., Nizard, J., Christory, F., Samama, C. ‐., et al. (2018) · Transfusion Medicine · doi:10.1111/tme.12443 · Cited by 177
How I treat unexplained refractory iron deficiency anemia
Hershko, C., & Camaschella, C. (2014) · Blood · doi:10.1182/blood-2013-10-512624 · Cited by 170
Current misconceptions in diagnosis and management of iron deficiency.
Múñoz, M., Gómez‐Ramírez, S., Besser, M. W., Pavía, J., Gomollón, F., Liumbruno, G. M., Bhandari, S., Cladellas, M., Shander, A., & Auerbach, M. (2017) · PubMed · doi:10.2450/2017.0113-17 · Cited by 168
Self-citationPisani, A., Riccio, E., Sabbatini, M., Andreucci, M., Del Rio, A., & Visciano, B. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu357 · Cited by 162
Quintanar-Guerrero, D., Ganem-Quintanar, A., Allémann, E., Fessi, H., & Doelker, E. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809006840 · Cited by 157
Non‐anaemic iron deficiency – a disease looking for recognition of diagnosis: a systematic review
Pratt, J. J., & Khan, K. S. (2016) · European Journal of Haematology · doi:10.1111/ejh.12645 · Cited by 126
Franceschi, L. D., Iolascon, A., Taher, A. T., & Cappellini, M. D. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.04.018 · Cited by 126
The Liver in Regulation of Iron Homeostasis
Rishi, G., & Subramaniam, V. N. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00004.2017 · Cited by 124
Leal-Noval, S. R., Múñoz, M., Asuero, M., Contreras, E., García‐Erce, J. A., Llau, J. V., Moral, V., Páramo, J. A., & Quintana, M. (2013) · Europe PMC (PubMed Central) · doi:10.2450/2013.0029-13 · Cited by 114
Red blood cell transfusion policy: a critical literature review.
Franchini, M., Marano, G., Mengoli, C., Pupella, S., Vaglio, S., Múñoz, M., & Liumbruno, G. M. (2017) · Europe PMC (PubMed Central) · doi:10.2450/2017.0059-17 · Cited by 111
Constante, M., Fragoso, G., Lupien-Meilleur, J., Calvé, A., & Santos, M. M. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001089 · Cited by 106
Anemia of chronic disease and defective erythropoietin production in patients with celiac disease
Bergamaschi, G., Markopoulos, K., Albertini, R., Di Sabatino, A., Biagi, F., Ciccocioppo, R., Arbustini, E., & Corazza, G. R. (2008) · Haematologica · doi:10.3324/haematol.13255 · Cited by 102
Parisi, F., Berti, C., Mandò, C., Martinelli, A., Mazzali, C., & Cetin, I. (2016) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2016.1224841 · Cited by 88
Iron deficiency and anaemia in bariatric surgical patients: causes, diagnosis and proper management.
Múñoz, M., Romero, F. B., Gómez‐Ramírez, S., Campos, A., & García‐Erce, J. A. (2010) · PubMed · doi:10.3305/nh.2009.24.6.4547 · Cited by 87
Self-citationThe safety of available treatment options for iron-deficiency anemia
Múñoz, M., Gómez‐Ramírez, S., & Bhandari, S. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1400009 · Cited by 78
Self-citationKiss, L., Hellinger, É., Pilbat, A., Kittel, Á., Török, Z., Füredi, A., Szakács, G., Veszelka, S., Sipos, P., Ózsvári, B., et al. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24085 · Cited by 65
Mafodda, A., Giuffrida, D., Prestifilippo, A., Azzarello, D., Giannicola, R., Mare, M., & Maisano, R. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-017-3690-z · Cited by 61
The Italian Regulatory Guidelines for the implementation of Patient Blood Management.
Vaglio, S., Gentili, S., Marano, G., Pupella, S., Rafanelli, D., Biancofiore, G., Antonioli, P., Velati, C., & Liumbruno, G. M. (2017) · Europe PMC (PubMed Central) · doi:10.2450/2017.0060-17 · Cited by 60
Management of anemia in patients with congestive heart failure
Tim Goodnough, L., Comin‐Colet, J., Leal‐Noval, S., Ozawa, S., Takere, J., Henry, D., Javidroozi, M., Hohmuth, B., Bisbe, E., Gross, I., et al. (2017) · American Journal of Hematology · doi:10.1002/ajh.24595 · Cited by 58
Aapro, M., Beguin, Y. P., Bokemeyer, C., Dicato, M. A., Gascón, P., Glaspy, J. A., Hofmann, A., Link, H., Littlewood, T. J., Ludwig, H., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy323 · Cited by 57
In vitro identification of targeting ligands of human M cells by phage display
Fiévez, V., Plapied, L., Plaideau, C., Legendre, D., Rieux, A. D., Pourcelle, V., Freichels, H., Jérôme, C., Marchand, J., Préat, V., et al. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.023 · Cited by 55
Elli, L., Ferretti, F., Branchi, F., Tomba, C., Lombardo, V., Scricciolo, A., Doneda, L., & Roncoroni, L. (2018) · Nutrients · doi:10.3390/nu10030330 · Cited by 55
Clinical Use of Erythropoietic Stimulating Agents in Myelodysplastic Syndromes
Santini, V. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-s3-35 · Cited by 51
Sucrosomial® iron absorption studied by in vitro and ex-vivo models
Fabiano, A., Brilli, E., Fogli, S., Beconcini, D., Carpi, S., Tarantino, G., & Zambito, Y. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.10.021 · Cited by 48
Self-citationEx Vivo and in Vivo Study of Sucrosomial® Iron Intestinal Absorption and Bioavailability
Fabiano, A., Brilli, E., Mattii, L., Testai, L., Moscato, S., Citi, V., Tarantino, G., & Zambito, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092722 · Cited by 47
Self-citationSucrosomial® Iron Supplementation in Mice: Effects on Blood Parameters, Hepcidin, and Inflammation
Asperti, M., Gryzik, M., Brilli, E., Castagna, A., Corbella, M., Gottardo, R., Girelli, D., Tarantino, G., Arosio, P., & Poli, M. (2018) · Nutrients · doi:10.3390/nu10101349 · Cited by 44
Self-citationPrevalence of anaemia and iron deficiency in Portugal: the EMPIRE study
Fonseca, C., Marques, F., Robalo Nunes, A., Belo, A., Brilhante, D., & Cortez, J. (2016) · Internal Medicine Journal · doi:10.1111/imj.13020 · Cited by 40 · cited 1×
“Iron deficiency (58%), with (41%) or without (18%) anemia, was also highly prevalent [84].”
BackgroundGiordano, G., Napolitano, M., Battista, V. D., & Lucchesi, A. (2020) · Annals of Hematology · doi:10.1007/s00277-020-04361-3 · Cited by 37
Stein, J. M., Aksan, A., Farrag, K., Dignass, A. U., & Radeke, H. H. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1391790 · Cited by 36
Scardino, M., Matteo, B. D., Martorelli, F., Tanzi, D., Kon, E., & D’Amato, T. (2018) · International Orthopaedics · doi:10.1007/s00264-018-4149-7 · Cited by 33
The post-operative management of anaemia: more efforts are needed.
Múñoz, M., Franchini, M., & Liumbruno, G. M. (2018) · Blood transfusion · doi:10.2450/2018.0036-18 · Cited by 33
Ciudin, A., Simó‐Servat, O., Balibrea, J. M., Vilallonga, R., Hernández, C., Simó, R., & Mesa, J. (2017) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2017.10.007 · Cited by 31
Fonseca, C., Araújo, M., Moniz, P., Marques, F., Araújo, I., Costa, L., Rodrigues, J., Frade, L., Botella, A., Jesus, S., et al. (2017) · European Journal of Haematology · doi:10.1111/ejh.12963 · Cited by 30
Ramírez, S. G., Remacha, A. F., & Gómez, M. M. (2017) · Medicina Clínica · doi:10.1016/j.medcli.2017.06.025 · Cited by 30
Macdougall, I. C., Bock, A. H., Carrera, F., Eckardt, K., Gaillard, S., Wyck, D. V., Meier, Y., Larroque, S., Perrin, A., Simon, D., et al. (2017) · Clinical Nephrology · doi:10.5414/cn109198 · Cited by 30
Iron Therapy Challenges for the Treatment of Nondialysis CKD Patients
Locatelli, F., Mazzaferro, S., & Yee, J. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00080116 · Cited by 28
Toblli, J. E., Cao, G., Olivieri, L., & Angerosa, M. (2008) · Pharmacology · doi:10.1159/000142728 · Cited by 27
Brilli, E., Romano, A., Fabiano, A., Zambito, Y., Raimondo, F. D., & Tarantino, G. (2016) · Blood · doi:10.1182/blood.v128.22.3618.3618 · Cited by 26
Self-citationA child with severe iron-deficiency anemia and a complex TMPRSS6 genotype
Capra, A. P., Ferro, E., Cannavò, L., Rosa, M. A. L., & Zirilli, G. (2017) · Hematology · doi:10.1080/10245332.2017.1317990 · Cited by 24
Ramírez, S. G., Remacha, A. F., & Gómez, M. M. (2017) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2017.10.027 · Cited by 23
Wu, Z., & Nakanishi, H. (2011) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-011-0123-4 · Cited by 22
GIORDANO, G., Mondello, P., Tambaro, R., Perrotta, N., D’Amico, F., D'AVETA, A., BERARDI, G., Carabellese, B., Patriarca, A., Corbi, G., et al. (2015) · Molecular and Clinical Oncology · doi:10.3892/mco.2015.555 · Cited by 21
Position paper on management of iron deficiency in adult cancer patients
Barni, S., Gascón, P., Petrelli, F., García‐Erce, J. A., Pedrazzoli, P., Rosti, G., Giordano, G., Mafodda, A., & Múñoz, M. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2017.1343140 · Cited by 21
Sucrosomial Iron®: A New Highly Bioavaible Oral Iron Supplement
Tarantino, G., Brilli, E., Zambito, Y., Giordano, G., & Equitani, F. (2015) · Blood · doi:10.1182/blood.v126.23.4561.4561 · Cited by 19
Self-citationTakaishi, N., Satsu, H., & Shimizu, M. (2006) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.60306 · Cited by 13
Barni, S. (2016) · Expert Review of Hematology · doi:10.1080/17474086.2016.1217153 · Cited by 10
Darbà, J., & Ascanio, M. (2018) · Clinical Drug Investigation · doi:10.1007/s40261-018-0666-9 · Cited by 7
The Potential of Sucrose Esters to be used as Oral Absorption Enhancers
Kis, L. (2010) · Scientia Pharmaceutica · doi:10.3797/scipharm.cespt.8.pot01 · Cited by 6
Research works printed but not linked: 11
- Starzynski, 2017, Comparison of the therapeutical potential of oral Sucrosomial® iron and parenteral iron dextran supplementations in neonatal iron deficiency anemia in pigs, Am. J. Hematol., 92, E286
- Brilli, E., Barnadas, R., Camacho, M., Giordano, G., and Tarantino, G. (2018, January 8–11). Sucrosomial® Iron Absorption Involves M Cells Interaction. Proceedings of the European Iron Club Annual Meeting, Zürich, Switzerland.
- Berardi, 2016, Efficacy of oral Sucrosomial® iron in puerperium anemia, Exp. Rev. Hematol., 9, 40
- Barni, 2017, Upfront use of Sucrosomial® iron prevents transfusions in cancer patients on chemotherapy, Support. Care Cancer, 25, S144
- Bastida, 2016, Efficacy and tolerability of Sucrosomial iron supplementation in IBD patients with iron deficiency anemia and intolerance to iron oral salts, Exp. Rev. Hematol., 9, 6
- Stuklov, N.I., Basiladze, I.G., Pivnik, A.V., Knyazev, O.V., and Parfenov, A.I. (2018). Characteristics and modern treatment of iron deficiency syndromes in inflammatory bowel diseases. Exp. Rev. Hematol., 10, in press.
- Farinati, F., and Maddalo, G. (2018). Iron and/or B12 deficient anemia in autoimmune gastritis. High dose sucrosomial iron supplementation: Preliminary data of a single center experience. Exp. Rev. Hematol., 10, in press.
- Shipton, 2018, Deficiencies of vitamin B12, folate and iron over 4 years of follow-up post-bariatric surgery [abstract], Br. J. Surg., 105, 28
- Karavidas, A., Trogkanis, E., Farmakis, D., Papingiotis, G., Matzaraki, V., Perpinia, A., and Parissis, J. (2018). Oral sucrosomial iron improves quality of life in heart failure patients with iron deficiency: A preliminary proof-of-concept study. Exp. Rev. Hematol., 10, in press.
- Cabrera, P., Gómez, S., Herrero, V., Martín, E., Pavía, J., and Muñoz, M. (2016, January 2–3). Prevalence and consequences of anaemia among patients hospitalised at the internal medicine ward: A single centre audit. Proceedings of the 15th European Congress of Internal Medicine, Amsterdam, The Netherlands.
- Giordano, 2016, Reduction of inflammatory markers with liposomal iron (Sideral®). Pre-clinical and clinical results, Exp. Rev. Hematol., 9, S17
Cited by
Pasricha, S.-R., Tye-Din, J., Muckenthaler, M. U., & Swinkels, D. W. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32594-0 · Cited by 1,069
Iron deficiency anaemia: pathophysiology, assessment, practical management
Kumar, A., Sharma, E., Marley, A., Samaan, M. A., & Brookes, M. J. (2022) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2021-000759 · Cited by 344
Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis, and Treatment
Batchelor, E. K., Kapitsinou, P., Pergola, P. E., Kovesdy, C. P., & Jalal, D. I. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019020213 · Cited by 334
Prevention of iron deficiency anemia in infants and toddlers
Sundararajan, S., & Rabe, H. (2020) · Pediatric Research · doi:10.1038/s41390-020-0907-5 · Cited by 219
Badura, K., Janc, J. J., Wąsik, J., Gnitecki, S., Skwira, S., Młynarska, E., Rysz, J., & Franczyk, B. (2024) · Biomedicines · doi:10.3390/biomedicines12061191 · Cited by 203
Metadata
- Authors
- Gómez-Ramírez, S., Brilli, E., Tarantino, G., & Muñoz, M.
- Affiliations
- Department of Internal Medicine, University Hospital Virgen de la Victoria. Campus de Teatinos, 2010 Málaga, Spain
- Scientific Department, Alesco S.r.l. Via delle Lenze, 216/B, 56122 Pisa, Italy
- PharmaNutra SpA (Italy) (IT)
- Perioperative Transfusion Medicine, Department of Surgical Specialties, Biochemistry and Immunology, School of Medicine, Campus de Teatinos, 29071 Málaga, Spain
- Venue
- Pharmaceuticals
- Publisher
- MDPI AG
- Published
- 2018-10-04
- Volume
- 11
- Issue
- 4
- Pages
- 97
- ISSN
- 1424-8247 (ISSN-L)
- PMC
- PMC6316120
- OpenAlex
- W2895639972
- Cited by
- 132
- References
- 82
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 28 · 2023: 19 · 2022: 14 · 2021: 20 · 2020: 17 · 2019: 7 · 2018: 1
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Pharmaceuticals (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- sucrosomial iron, oral iron supplementation, iron deficiency, ferric pyrophosphate, phospholipid bilayers, M cells, iron bioavailability, gastrointestinal tolerance, chronic kidney disease, cancer patients, bariatric surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.